Clik here to view.
10 Studies on Orelabrutinib Selected at the Upcoming 64th Annual Meeting of ASH
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that 10 studies on the BTK...
View ArticleClik here to view.
SnapLogic Powers Abano Healthcare’s Journey to Modernisation
SYDNEY, Australia Abano Healthcare, Australasia’s largest dental support organisation (DSO), leverages SnapLogic, a leader in intelligent integration and enterprise automation, to power its...
View ArticleClik here to view.
2023年ザーイド・サステナビリティー賞のファイナリスト30組織を発表
アラブ首長国連邦アブダビ （ビジネスワイヤ） — 持続可能性における卓越性を表彰するアラブ首長国連邦の先駆的な世界的賞「ザーイド・サステナビリティー賞」の審査委員会が開催され、来年1月の2023年アブダビ・サステナビリティ・ウィーク（ADSW）での授賞式で発表される2023年サイクルの受賞者が選出されました。...
View ArticleClik here to view.
Turnstone Biologics to Present Preclinical Data From Novel TIL Therapy...
SAN DIEGO Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid tumors, today announced that two posters showing...
View ArticleClik here to view.
2023年扎耶德可持续发展奖公布30名决赛入围者名单
阿联酋阿布扎比 (美国商业资讯)–旨在表彰可持续发展领域卓越成就的阿联酋开创性全球大奖“扎耶德可持续发展奖”(Zayed Sustainability Prize)举行了评审团会议，评选出了当前2023年大奖的获奖者，获奖名单将在2023年1月举办的2023年阿布扎比可持续发展周(ADSW)颁奖典礼上公布。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
レビタスバイオがシリーズC資金調達を完了
米カリフォルニア州メンロパーク （ビジネスワイヤ） — ライフサイエンス市場にエンドツーエンドの試料処理・分析サービスを提供する一流企業のレビタスバイオ（www.levitasbio.com）は、業界をリードする強力な細胞分析法を提供するという使命を推進するため、シリーズCラウンドで3500万ドルの資金調達を完了したと発表しました。...
View ArticleClik here to view.
BiomeBank Announces World First Regulatory Approval for Donor Derived...
ADELAIDE, Australia BiomeBank today announced the first regulatory approval for a donor derived microbiome drug product worldwide. The Therapeutic Goods Administration (TGA) approved BiomeBank’s...
View ArticleClik here to view.
LevitasBio完成C轮融资
加州门洛帕克 (美国商业资讯)–为生命科学市场提供端到端样本处理和分析服务的领先公司LevitasBio, Inc. (www.levitasbio.com)宣布，其已完成C轮3500万美元的融资，用以推进其提供强大的行业领先细胞分析技术的使命。...
View ArticleClik here to view.
Vedanta Biosciences to Present at the 9th International Human Microbiome...
CAMBRIDGE, Mass. Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, today announced that Bernat Olle,...
View ArticleClik here to view.
Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone...
GENEVA MEDIMAPS GROUP (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced that its novel method for...
View ArticleClik here to view.
Exscientia and MD Anderson Launch Strategic Collaboration to Leverage AI in...
OXFORD, England & HOUSTON, Texas Exscientia plc (Nasdaq: EXAI) and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to align the patient-centric...
View ArticleClik here to view.
Exscientia和MD安德森启动战略合作，利用人工智能开发新型肿瘤疗法
英格兰牛津和得克萨斯州休斯敦 (美国商业资讯)–Exscientia plc (Nasdaq: EXAI)和得克萨斯大学MD安德森癌症中心今天宣布达成了一项战略合作，将Exscientia以患者为中心的人工智能(AI)能力与MD安德森的药物发现和开发专长相结合，以推进新型小分子肿瘤疗法。...
View ArticleClik here to view.
CANbridge Pharmaceuticals Granted Orphan Drug Designation for CAN 106 for the...
BEIJING & BURLINGTON, Mass. CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and...
View ArticleClik here to view.
HIROTSU BIO SCIENCE INC.: World’s First Test for Early-Stage Pancreatic...
TOKYO HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu; hereafter referred to as “HIROTSU”) is pleased to announce the commercialization of “N-NOSE plus...
View ArticleClik here to view.
APEC University Leaders’ Forum 2022 Successfully Concludes with High-level...
HONG KONG Business leaders, policy makers, and university presidents from APRU, a network of 60 leading research universities from 19 economies around the APEC region, convened at the Chulalongkorn...
View ArticleClik here to view.
Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye...
QUEBEC CITY & TOKYO Saguaro Technologies inc., a cell culture product company that offers a first-of-a-kind dye technology, and Funakoshi Co., Ltd., a top Japanese distributor of life science...
View ArticleClik here to view.
The New England Journal of Medicine and NEJM Group partner with Wolters...
WALTHAM, Mass. Wolters Kluwer Health and NEJM Group have entered into an exclusive partnership to ensure that more researchers and clinicians around the world can access the growing family of NEJM...
View ArticleClik here to view.
EdiGene Announces Completion of Last Patient Dosing in Phase I Clinical Trial...
BEIJING & WALTHAM, Mass. EdiGene, Inc., a global, clinical-stage company focused on translating gene-editing technologies into transformative genetic medicines for patients with significant...
View ArticleClik here to view.
Neuraptive Therapeutics , Inc .宣布任命行业知名高管Robert R. Ruffolo博士为董事会新成员
费城 (美国商业资讯)–Neuraptive Therapeutics, Inc.是一家生物技术公司，致力于开发新型疗法和医疗产品，解决医生和受周围神经损伤影响的患者未获满足的需求。该公司宣布任命行业研发先驱Robert (Bob) R. Ruffolo, Jr.博士为公司董事会成员。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
《新英格兰医学杂志》和NEJM集团与Wolters Kluwer合作，扩大一流期刊的全球覆盖范围
马萨诸塞州沃尔瑟姆 (美国商业资讯)–Wolters Kluwer Health和NEJM集团建立了独家合作关系，确保更多世界各地的研究人员和临床医生能够获取日益壮大的NEJM集团系列期刊。基于多年的合作基础，这一扩大的伙伴关系使NEJM集团的期刊能够通过Wolters...
View Article